Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial tags : Collaboration save search
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma
Published: 2024-03-28 (Crawled : 11:00) - prnewswire.com
SLS | $1.505 6.74% 6.31% 1.6M
|
Health Technology
|
| O: -0.97%
H: 1.18%
C: -0.98%
gfh009 brukinsa cell collaboration trial therapy study
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
Published: 2024-03-05 (Crawled : 07:00) - globenewswire.com
NIPNF | News | $68.91 -52.94% 120
|
Technology Services
| Email alert
Add to watchlist
tg4050 vaccine cancer collaboration trial
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
Published: 2024-02-23 (Crawled : 21:00) - biospace.com/
SLNCF | $8.0 -65.0% 1.3K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SLN | $21.98 1.95% 1.91% 120K
|
Health Technology
|
| O: 3.34%
H: 2.83%
C: -1.59%
million payment astrazeneca collaboration trial therapeutics milestone
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial
Published: 2024-02-22 (Crawled : 12:00) - globenewswire.com
IMCR | $54.765 0.34% 0.34% 430K
|
Manufacturing
|
| O: 0.91%
H: 0.95%
C: -2.05%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.65%
H: 1.63%
C: 1.48%
melanoma nivolumab collaboration trial advanced agreement
Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
Published: 2024-02-14 (Crawled : 13:00) - globenewswire.com
ERAS | $1.795 -2.45% -2.51% 650K
|
|
| O: 2.99%
H: 2.03%
C: 0.58%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.02%
H: 0.24%
C: 0.01%
trials collaboration trial
Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging
Published: 2024-02-13 (Crawled : 14:00) - globenewswire.com
LNTH | $62.34 1.4% 1.38% 1.3M
|
Health Technology
|
| O: -2.19%
H: 1.36%
C: -0.76%
institute collaboration tau trial imaging
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Published: 2024-02-06 (Crawled : 14:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
collaboration trial sanofi
Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
Published: 2024-01-24 (Crawled : 14:30) - globenewswire.com
CAPR | $5.055 -8.92% -9.79% 940K
|
Health Technology
|
| O: 2.18%
H: 6.4%
C: -3.32%
vaccine sars-cov-2 collaboration trial therapeutics
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform
Published: 2024-01-05 (Crawled : 13:30) - biospace.com/
CVAC | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 0.71%
H: 4.24%
C: 2.12%
covid-19 vaccine positive collaboration program technology platform
Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma
Published: 2024-01-04 (Crawled : 22:00) - biospace.com/
RIGL | $1.06 -4.51% -4.72% 1.2M
|
Health Technology
|
| O: 2.76%
H: 2.68%
C: 0.0%
collaboration trial
Innovent and Xuanzhu Enter into Clinical Trial Collaboration Investigating Combination Therapy of Sintilimab (PD-1 inhibitor) and A Novel ADC Candidate for Advanced Solid Tumors in China
Published: 2023-12-28 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: -1.32%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.08%
H: 0.81%
C: -0.19%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.52%
H: 0.72%
C: -0.34%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.35%
H: 1.07%
C: -0.27%
candidate tumors collaboration trial advanced china therapy
Nuvectis Pharma, Inc. Announces a Collaboration with Mayo Clinic to Evaluate NXP800 in an Investigator-Sponsored Clinical Trial in Cholangiocarcinoma
Published: 2023-12-18 (Crawled : 13:00) - globenewswire.com
NVCT | $6.725 -0.52% -0.52% 81K
|
|
| O: -0.23%
H: 4.78%
C: -1.63%
nxp800 collaboration trial
BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn
Published: 2023-12-12 (Crawled : 21:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
disease global collaboration trial
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -3.28%
hbv003 biopharma collaboration trial
Karyopharm Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Novel CELMoD™ Agent CC- 92480 Mezigdomide in Combination with Selinexor in Patients with Relapsed/Refractory Multiple Myeloma
Published: 2023-10-30 (Crawled : 13:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 1.39%
H: 0.32%
C: -0.93%
KPTI | $1.265 -8.33% -9.09% 1.3M
|
Health Technology
|
| O: 2.92%
H: 6.08%
C: -3.35%
collaboration trial
BioAge Labs Announces Plans for Phase 2 Trial of First-in-Class Apelin Receptor Agonist BGE-105/Azelaprag Co-Administered With Tirzepatide for Treatment of Obesity, in Collaboration With Lilly’s Chorus Organization
Published: 2023-10-26 (Crawled : 00:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -1.68%
H: 0.0%
C: 0.0%
bge-105 agonist treatment collaboration trial tirzepatide
MediWound Announces Collaboration with 3M on EscharEx® Phase III StudyMediWound to join forces with 3M Health Care, world’s largest wound care company in pivotal study for patients with venous leg ulcers
Published: 2023-10-11 (Crawled : 11:00) - biospace.com/
MMM | $91.48 0.57% 0.0% 3M
|
Producer Manufacturing
|
| O: 0.18%
H: 0.2%
C: -0.45%
MDWD | $16.94 -2.87% -2.95% 42K
|
Health Technology
|
| O: 0.32%
H: 0.91%
C: -4.05%
escharex company health care collaboration study
Boundless Bio Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate VERZENIO® (abemaciclib) in Combination with BBI-355 in Patients with CDK4 or CDK6 Amplified Solid Tumors
Published: 2023-09-19 (Crawled : 13:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.06%
H: 1.19%
C: 0.58%
bbi-355 verzenio tumors collaboration trial agreement
Celcuity Enters into a Clinical Trial Collaboration and Supply Agreement with Bayer to Provide Nubeqa® (darolutamide) for Planned Phase 1b/2 Clinical Trial
Published: 2023-08-22 (Crawled : 20:00) - globenewswire.com
CELC | $16.4 -3.59% -3.72% 200K
|
Commercial Services
|
| O: -0.91%
H: 7.94%
C: 4.48%
nubeqa collaboration trial agreement
PAN-TB Collaboration Announces the Start of a Phase 2 Clinical Trial to Evaluate Two Novel Tuberculosis Treatment Regimens
Published: 2023-08-09 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
start treatment collaboration trial phase 2
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.